跳至主要内容
临床试验/CTRI/2025/04/084295
CTRI/2025/04/084295尚未招募2/3 期

Open Randomized Control Clinical Trial of Pippalyadi vati in Vataja Pratishyaya with special reference to Acute Rhinitis (COMMON COLD)

Dr Poonam Laxman Powar1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2025年4月21日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
84
试验地点
1
主要终点
Pippalyadi Vati is More Effective Than Fexofenadine in Acute Rhinitis (Common Cold )

研究概览

简要总结

Based on the physician diagnosis incidence of Acute Rhinitis in India ranges

between20% to 30%. 17 Studies have shown that prevalence of Acute

rhinitis has been increasing in India over past few years. Thus the study will

be carried out to find out the solution for the relief from Acute Rhinitis

(VatajaPratishyaya).

The disease VatajaPratishyaya which is due to vitiation of vatadosha in

nasa region is comparable with Acute Rhinitis which is more common now

a day due to increased pollution and changes in lifestyle.VatajaPratishyaya

has symptoms like Aanaddhapihita, Tanustrava, Kshawathu,which are also

present in Acute Rhinitis(common cold) as a nasal blockage, rhinorrhoea,

sneezing.

Treatment for the Acute Rhinitis(common cold) is antihistamines and

steroids etc and their side effects are drowsiness,dizziness and headache.

Ayurveda has much effective treatment modalities for VatajaPratishyaya.

Hence the present study will be carried out to evaluate the efficacy of

PippalyadiVatiinVatajaPratishyaya.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from theVatajaPratishyaya (Acute Rhinitis-common cold).
  • Patients of Age Group 18 To 60 years, irrespective of their gender, religion, occupation.
  • All patients having signs and symptoms.
  • 1.Aanaddhapihita (Nasal Obstruction) 2.Tanustrava (Rhinorrhoea)
  • Kshavathu (Sneezing)
  • jwara (fever).

排除标准

  • Pregnant women and children
  • History of congenital disorder of nose
  • Known cases of chronic specific infective rhinitis, syphilis, leprosy, tuberculosis, Lupus vulgaris, fungal infections,
  • Patients with nasal polyp, neoplasm.

结局指标

主要结局

Pippalyadi Vati is More Effective Than Fexofenadine in Acute Rhinitis (Common Cold )

时间窗: 1 BD for 7 days

次要结局

  • Pippalyadi vati is equally effective as Fexofenadine in Acute Rhinitis (Common Cold).(1 BD for 7 days)

研究者

发起方
Dr Poonam Laxman Powar
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Poonam Laxman Powar

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate research centre Ashta

研究点 (1)

Loading locations...

相似试验